To further confirm that Sema7A has a distinct role in the pathogenesis of RA in vivo, we introduced anti-Sema7A antibody into a T-cell- and monocyte-dependent animal model of RA, namely, CIA. Here, SEMA7A is linked to rheumatoid arthritis.